Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Entire DC Network
Mediation Of Recurrent Hypoglycemia's Physiological And Behavioral Effects In The Hippocampus By Glucocorticoids, Danielle Osborne
Mediation Of Recurrent Hypoglycemia's Physiological And Behavioral Effects In The Hippocampus By Glucocorticoids, Danielle Osborne
Legacy Theses & Dissertations (2009 - 2024)
Recurrent hypoglycemia (RH) occurs with the over administration of insulin resulting in severe hypoglycemia on a repetitive basis. This occurs most commonly among Type I Diabetics who rely on exogenous insulin replacement for management of their disease; however it is becoming increasingly common among Type II Diabetics. Although cognitive deficits are reported during hypoglycemia, the period following restoration of euglycemia has been denoted by improved hippocampally-mediated short-term and working memory in humans and rodents, respectively. RH is also associated with an altered glucocorticoid secretion profile in response to hypoglycemia. In vitro and in vivo approaches were utilized with the goal …
The Role Of Glucose Transporter 4 During Cognitive Enhancement By Angiotensin Iv, Leslie Ann Sandusky
The Role Of Glucose Transporter 4 During Cognitive Enhancement By Angiotensin Iv, Leslie Ann Sandusky
Legacy Theses & Dissertations (2009 - 2024)
Alzheimer's disease (AD) is a progressive neurodegenerative disorder, characterized behaviorally by profound cognitive impairment. Currently, there is no cure for this disorder and available therapeutics only slow the progression of cognitive decline in a subset of the AD population Recent research has shifted to upregulation of the insulin signaling pathway as a mechanism to restore cognition in the AD population, as this system is known to be impaired in the AD brain. A possible novel therapeutic for the treatment of cognitive impairment is Angiotensin IV (Ang IV). Ang IV is an endogenous pentapeptide inhibitor of the insulin-regulated aminopeptidase (IRAP) and …